

UN General Assembly Ends With Few Breakthroughs
The United Nations headquarters in New York once again became the center of international diplomacy. Presidents, prime ministers, foreign ministers, and representatives from more than 190 countries participated in the High-Level Week of the 81st General Assembly. Between September 22 and 28, discussions were dominated by ongoing wars, tensions between major powers, climate change, artificial intelligence, and the economic situation of developing countries. The official theme,


New Trends Are Changing the Alcohol Market
Alcohol consumption among American teenagers has declined considerably over the past several decades, but that does not mean young people are abandoning alcohol altogether. While high school students are drinking much less than previous generations, the data show a different picture among members of Generation Z who are old enough to legally drink. At the same time, the alcoholic beverage market is undergoing a transformation shaped by new preferences, greater attention to he


FDA Approves Breast Cancer Treatment Guided by a Mutation
The Food and Drug Administration (FDA) granted accelerated approval to ETCAMAH (camizestrant), an oral treatment developed by the pharmaceutical company AstraZeneca, for a specific group of patients with advanced or metastatic breast cancer. This medication is indicated for adult patients with hormone-sensitive, HER2-negative breast cancer when an ESR1 gene mutation is detected during treatment with hormonal therapy and a CDK4/6 inhibitor. There are different options availabl

































